Related Experiment Video

Updated: Jul 20, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population

M Buc1, M Bucová, J Javor

  • 1Department of Immunology, Comenius University School of Medicine, Czech Republic. milan.buc@fmed.uniba.sk

Endocrine Regulations
|September 13, 2006
PubMed

Insights

This study identified specific human leukocyte antigen (HLA) alleles, DQB1*0302 and DQA1*0301, as significantly associated with type 1A diabetes mellitus (DM-1A) in the Slovak population. These findings highlight key genetic markers for DM-1A risk in this demographic.

Area of Science:

  • Immunogenetics
  • Human Genetics
  • Endocrinology

Background:

  • Human leukocyte antigen (HLA) complex associations with type 1A diabetes mellitus (DM-1A) are established in Caucasian populations.
  • No prior studies have investigated these associations within the Slovak population.

Purpose of the Study:

  • To investigate the association between specific HLA-DQB1, HLA-DQA1, and HLA-DRB1 alleles and DM-1A in the Slovak population.
  • To identify potential genetic markers for DM-1A risk in this specific ethnic group.

Main Methods:

  • HLA typing was performed using the PCR-SSP method on 460 DM-1A patients and control groups.
  • Specific alleles analyzed included HLA-DQB1 (460 patients), HLA-DQA1 (97 patients), and HLA-DRB1 (146 patients).
  • Statistical analysis employed the Fisher exact test to compare allele frequencies between patients and healthy subjects.

Main Results:

  • HLA-DQB1*0302 and DQB1*0201 were found at higher frequencies in DM-1A patients compared to healthy subjects.
  • Conversely, DQB1*0301, DQB1*0602, and DQB1*0603 showed decreased frequencies in DM-1A patients.
  • Specific HLA-DQA1 and HLA-DRB1 alleles were also identified with altered frequencies, with some forming characteristic haplotypes associated with DM-1A.

Conclusions:

  • Specific HLA-DQB1, HLA-DQA1, and HLA-DRB1 alleles are significantly associated with DM-1A in the Slovak population.
  • The identified alleles and haplotypes, particularly DQB1*0302/DQA1*0301 and DQB1*0201/DQA1*0501, serve as important genetic markers for DM-1A.
  • This study provides crucial insights into the genetic predisposition of DM-1A in Slovaks, filling a gap in previous research.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...